These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32486489)

  • 1. Combined Targeting of Glioblastoma Stem-Like Cells by Neutralizing RNA-Bio-Drugs for STAT3.
    Esposito CL; Nuzzo S; Ibba ML; Ricci-Vitiani L; Pallini R; Condorelli G; Catuogno S; de Franciscis V
    Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32486489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma.
    Esposito CL; Nuzzo S; Catuogno S; Romano S; de Nigris F; de Franciscis V
    Mol Ther Nucleic Acids; 2018 Mar; 10():398-411. PubMed ID: 29499951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Discovery of RNA Aptamers that Selectively Bind Glioblastoma Stem Cells.
    Affinito A; Quintavalle C; Esposito CL; Roscigno G; Vilardo C; Nuzzo S; Ricci-Vitiani L; De Luca G; Pallini R; Kichkailo AS; Lapin IN; de Franciscis V; Condorelli G
    Mol Ther Nucleic Acids; 2019 Dec; 18():99-109. PubMed ID: 31541799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combined microRNA-based targeted therapeutic approach to eradicate glioblastoma stem-like cells.
    Esposito CL; Nuzzo S; Kumar SA; Rienzo A; Lawrence CL; Pallini R; Shaw L; Alder JE; Ricci-Vitiani L; Catuogno S; de Franciscis V
    J Control Release; 2016 Sep; 238():43-57. PubMed ID: 27448441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetraspanin CD9 stabilizes gp130 by preventing its ubiquitin-dependent lysosomal degradation to promote STAT3 activation in glioma stem cells.
    Shi Y; Zhou W; Cheng L; Chen C; Huang Z; Fang X; Wu Q; He Z; Xu S; Lathia JD; Ping Y; Rich JN; Bian XW; Bao S
    Cell Death Differ; 2017 Jan; 24(1):167-180. PubMed ID: 27740621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin inhibits tumorigenicity of glioblastoma stem-like cells via the AKT-EZH2-STAT3 signaling axis.
    Chen X; Hao A; Li X; Du Z; Li H; Wang H; Yang H; Fang Z
    J Pineal Res; 2016 Sep; 61(2):208-17. PubMed ID: 27121240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells.
    Russo V; Paciocco A; Affinito A; Roscigno G; Fiore D; Palma F; Galasso M; Volinia S; Fiorelli A; Esposito CL; Nuzzo S; Inghirami G; de Franciscis V; Condorelli G
    Mol Ther Nucleic Acids; 2018 Dec; 13():334-346. PubMed ID: 30340138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells.
    Camorani S; Crescenzi E; Colecchia D; Carpentieri A; Amoresano A; Fedele M; Chiariello M; Cerchia L
    Oncotarget; 2015 Nov; 6(35):37570-87. PubMed ID: 26461476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An RNA Aptamer Targeting the Receptor Tyrosine Kinase PDGFRα Induces Anti-tumor Effects through STAT3 and p53 in Glioblastoma.
    Yoon S; Wu X; Armstrong B; Habib N; Rossi JJ
    Mol Ther Nucleic Acids; 2019 Mar; 14():131-141. PubMed ID: 30594071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT3 is essential for the maintenance of neurosphere-initiating tumor cells in patients with glioblastomas: a potential for targeted therapy?
    Villalva C; Martin-Lannerée S; Cortes U; Dkhissi F; Wager M; Le Corf A; Tourani JM; Dusanter-Fourt I; Turhan AG; Karayan-Tapon L
    Int J Cancer; 2011 Feb; 128(4):826-38. PubMed ID: 20473906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of miR-181a suppresses the formation of glioblastoma stem cells by targeting the Notch2 oncogene and correlates with good prognosis in patients with glioblastoma multiforme.
    Huang SX; Zhao ZY; Weng GH; He XY; Wu CJ; Fu CY; Sui ZY; Ma YS; Liu T
    Biochem Biophys Res Commun; 2017 May; 486(4):1129-1136. PubMed ID: 28389242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway.
    Li H; Chen L; Li JJ; Zhou Q; Huang A; Liu WW; Wang K; Gao L; Qi ST; Lu YT
    J Hematol Oncol; 2018 May; 11(1):70. PubMed ID: 29843746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of targeting microRNA-10b in established intracranial glioblastoma: first steps toward the clinic.
    Teplyuk NM; Uhlmann EJ; Gabriely G; Volfovsky N; Wang Y; Teng J; Karmali P; Marcusson E; Peter M; Mohan A; Kraytsberg Y; Cialic R; Chiocca EA; Godlewski J; Tannous B; Krichevsky AM
    EMBO Mol Med; 2016 Mar; 8(3):268-87. PubMed ID: 26881967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
    Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
    Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The STAT3-Regulated Autophagy Pathway in Glioblastoma.
    Laribee RN; Boucher AB; Madireddy S; Pfeffer LM
    Pharmaceuticals (Basel); 2023 Apr; 16(5):. PubMed ID: 37242454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardamonin induces apoptosis by suppressing STAT3 signaling pathway in glioblastoma stem cells.
    Wu N; Liu J; Zhao X; Yan Z; Jiang B; Wang L; Cao S; Shi D; Lin X
    Tumour Biol; 2015 Dec; 36(12):9667-76. PubMed ID: 26150336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT3 silencing by an aptamer-based strategy hampers the crosstalk between NSCLC cells and cancer-associated fibroblasts.
    Ibba ML; Ciccone G; Rotoli D; Coppola G; Fiorelli A; Catuogno S; Esposito CL
    Mol Ther Nucleic Acids; 2023 Jun; 32():111-126. PubMed ID: 37020682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted delivery of tumor suppressor microRNA-1 by transferrin-conjugated lipopolyplex nanoparticles to patient-derived glioblastoma stem cells.
    Wang X; Huang X; Yang Z; Gallego-Perez D; Ma J; Zhao X; Xie J; Nakano I; Lee LJ
    Curr Pharm Biotechnol; 2014; 15(9):839-46. PubMed ID: 25374033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Therapeutic Effects of the Neural Stem Cell-Targeting Antibody Nilo1 in Patient-Derived Glioblastoma Stem Cells.
    Rackov G; Iegiani G; Uribe D; Quezada C; Belda-Iniesta C; Escobedo-Lucea C; Silva A; Puig P; González-Rumayor V; Ayuso-Sacido Á
    Front Oncol; 2020; 10():1665. PubMed ID: 32974206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.